Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Illegal trade barriers discriminate against U.S. innovators

May 2, 2017

America has long led the world in medical innovation – which

Read More

Clinical Trials Awareness Week: Celebrating the impact of clinical research

May 1, 2017

Perhaps no partner is more critical to the R&D process than patients.

Read More

Medicare Monday: What the experts are saying about the Independent Payment Advisory Board

May 1, 2017

Stakeholders across the health care system are raising concerns about IPAB and calling for it to be repealed.

Read More

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

April 28, 2017

This blog post summarizes the event in partnership with The Atlantic, titled “Sequencing the Genome: Examining Modern Medicine”.

Read More

PhRMA Statement on 2017 Special 301 Report

April 28, 2017

Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President Jay Taylor issued the following statement today:

Read More

340B Spotlight: 340B hospitals continue to benefit from consolidation at expense of patients

April 27, 2017

Report shows how much 340B hospitals are benefiting from buying up community doctors’ offices and bringing them under the 340B umbrella.

Read More

A new era in genomics

April 26, 2017

With a clearer understanding of each individual’s own genetic makeup, America’s Biopharmaceutical Companies are making groundbreaking innovations that deli

Read More

Australia is making it harder to protect inventions. That’s bad for American businesses and jobs.

April 25, 2017

To ensure continued investment in breakthrough treatments and cures, innovators must be able to protect and enforce patents and other intellectual property.

Read More

Medicare Monday: Stakeholders raise concern with MedPAC’s proposed changes to drug purchasing program

April 24, 2017

A number of groups have called attention to the dangers of MedPAC's proposed drug value program.

Read More

The risks of counterfeit imported medicines

April 20, 2017

Dangers of drug importation and counterfeits

Read More